Per the program's published design paper (Giblin et al., Diabetes, Obesity and Metabolism , 2026), the core registrational program consists of four trials : TRIUMPH-1 (NCT05929066): 80-week weight management basket trial, adults with obesity/overweight without diabetes (N=2,339), with knee osteoarthritis and obstructive sleep apnea substudies nested inside it
Track sleep, stress, alcohol, and erection quality for two weeks
People taking GLP-1 medications who experience significant mood changes, increased irritability, or behavioral changes should report them to their prescribing clinician, as these effects would be relevant to ongoing safety monitoring
Wegovy and Ozempic delay gastric emptying, which could affect the absorption of oral medications
Semaglutide and NAION: What Current Research Shows The July 2024 Harvard study from Massachusetts Eye and Ear found that individuals prescribed Ozempic and other GLP-1 drugs were at a heightened risk for developing NAION
Alternatively, use a source of commercially soaked and sprouted seeds